Binimetinib, a Novel MEK1/2 Inhibitor, Exerts Anti-Leukemic Effects Under Inactive Status of PI3Kinase/Akt Pathway
International Journal of Hematology - Japan
doi 10.1007/s12185-019-02667-1
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 25, 2019
Authors
Publisher
Springer Science and Business Media LLC